NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Heron Therapeutics Inc (F: AXD2)

 
AXD2 Technical Analysis
2
As on 23rd Dec 2024 AXD2 STOCK Price closed @ 1.51 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.85 & Strong Buy for SHORT-TERM with Stoploss of 1.32 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AXD2STOCK Price

Open 1.51 Change Price %
High 1.51 1 Day 0.04 2.72
Low 1.51 1 Week -0.09 -5.62
Close 1.51 1 Month -0.22 -12.72
Volume 710 1 Year 0.28 22.76
52 Week High 3.46 | 52 Week Low 0.50
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
HGF2 7.40 1380.00%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
LDB 1.71 -92.57%
 
 
AXD2
Daily Charts
AXD2
Intraday Charts
Whats New @
Bazaartrend
AXD2
Free Analysis
 
AXD2 Important Levels Intraday
RESISTANCE1.51
RESISTANCE1.51
RESISTANCE1.51
RESISTANCE1.51
RESISTANCE1.51
RESISTANCE1.51
RESISTANCE1.51
RESISTANCE1.51
 
AXD2 Forecast December 2024
4th UP Forecast2.78
3rd UP Forecast2.37
2nd UP Forecast2.12
1st UP Forecast1.87
1st DOWN Forecast1.15
2nd DOWN Forecast0.9
3rd DOWN Forecast0.65
4th DOWN Forecast0.24
 
AXD2 Weekly Forecast
4th UP Forecast1.91
3rd UP Forecast1.78
2nd UP Forecast1.70
1st UP Forecast1.62
1st DOWN Forecast1.40
2nd DOWN Forecast1.32
3rd DOWN Forecast1.24
4th DOWN Forecast1.11
 
AXD2 Forecast2024
4th UP Forecast7.21
3rd UP Forecast5.38
2nd UP Forecast4.25
1st UP Forecast3.12
1st DOWN Forecast-0.1
2nd DOWN Forecast-1.23
3rd DOWN Forecast-2.36
4th DOWN Forecast-4.19
 
 
AXD2 Other Details
Segment EQ
Market Capital 948073728.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
AXD2 Address
AXD2
 
AXD2 Latest News
 
Your Comments and Response on Heron Therapeutics Inc
 
AXD2 Business Profile
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing HTX-011, an investigational, dual-acting, and fixed-dose combination of the local anesthetic bupivacaine with a low dose of the nonsteroidal anti-inflammatory drug meloxicam, which is in Phase III clinical trials for pain management; and HTX-034, which is in Phase Ib/II clinical trials for postoperative pain management. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California. Address: 4242 Campus Point Court, San Diego, CA, United States, 92121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service